The Atlanta Hawks have had two days off since defeating the Chicago Bulls on Wednesday night and now they will face as big of a challenge as there is in the NBA, going into Boston to face the ...
Atalanta Therapeutics is building on the growing attention around RNAi-based medicines with its $97 million Series B financing and plans to enter the clinic.